0001354457-18-000377.txt : 20180927
0001354457-18-000377.hdr.sgml : 20180927
20180927091629
ACCESSION NUMBER: 0001354457-18-000377
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20180927
DATE AS OF CHANGE: 20180927
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660719
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37691
BUSINESS ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
BUSINESS PHONE: 905-876-1118
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: The Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
The Nasdaq Stock Market LLC
0001660719
Aralez Pharmaceuticals Inc.
001-37691
7100 West Credit Avenue, Suite 101
Mississauga
A6
ONTARIO, CANADA
L5N 0E4
905 876 1118
Common Shares
17 CFR 240.12d2-2(b)
Amy Horton
Hearings Advisor
2018-09-27
EX-99.25
2
arlzdelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
September 27, 2018, Aralez Pharmaceuticals Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Aralez Pharmaceuticals Inc.
(the Company), effective at the opening of the trading
session on October 8, 2018. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified
of the Staffs determination on August 10, 2018. The Company
did not appeal the Staff determination to the
Hearings Panel, and the Staff determination to delist the
Company became final on August 21, 2018.